Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-06

Clinical Trial Update: Neurobiology of Opioid Dependence: 3 - 3 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the neurobiology of opioid dependence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Opioid-Related Disorders | Phase 2 | Status: WITHDRAWN